Activating Smoothened mutations in sporadic basal-cell carcinoma
1998 · Nature · 1,337 citations
https://doi.org/10.1038/34201
J
Jingwu Xie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
162
Papers
9.6K
Citations
45
h-index
74
i10-index
Jingwu Xie is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Hedgehog Signaling Pathway Studies & Epigenetics and DNA Methylation & Cancer-related Molecular Pathways. The author has an h-index of 45, co-authored 138 publications.
ORCID: 0000-0002-3674-332XPapers by this author
worksIdentification of Mutations in the Human PATCHED Gene in Sporadic Basal Cell Carcinomas and in Patients with the Basal Cell Nevus Syndrome
1998 · Journal of Investigative Dermatology · 307 citations
https://doi.org/10.1046/j.1523-1747.1998.00222.x
Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer
2016 · Oncogene · 297 citations
https://doi.org/10.1038/onc.2016.168
Promising molecular mechanisms responsible for gemcitabine resistance in cancer
2015 · Genes & Diseases · 179 citations
https://doi.org/10.1016/j.gendis.2015.07.003
Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene <i>MDR1</i>
2008 · Molecular and Cellular Biology · 123 citations
https://doi.org/10.1128/mcb.00244-08
The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
2018 · Oncogene · 94 citations
https://doi.org/10.1038/s41388-018-0553-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat